Literature DB >> 17977794

High levels of intracellular IL-4 are expressed in circulating apoptotic T cells in patients with tuberculosis and in community controls.

Hanne Veenstra1, Ralf Baumann, Pauline T Lukey, Nulda Beyers, Paul D van Helden, Gerhard Walzl.   

Abstract

Data concerning T helper cell phenotypes in response to Mycobacterium tuberculosis infection remain controversial. T lymphocyte intracellular interleukin-4 production in response to CD3 stimulation was determined by flow cytometry in 21 TB patients and 14 community controls. In supplementary experiments the association of interleukin-4 expression with apoptosis was investigated. A low percentage of CD4 T cells in both patients and controls expressed high levels of interleukin-4 (IL-4(high)). A larger subset of both CD4 and CD8 T cells of all subjects expressed low levels of intracellular IL-4 (IL-4(low)). Stimulated and unstimulated cells expressed IL-4(low) and IL-4(high). IL-4(low) percentages were lower in TB patients at diagnosis compared to controls while IL-4(high) percentages were higher in patients. Most IL-4(high) cells co-expressed active caspase-3, a marker for apoptosis. This co-expression was also shown in experimentally induced apoptotic Jurkat cells and peripheral blood neutrophils and monocytes. IL-4 levels may therefore not necessarily indicate a skewed Th cell phenotype, as our data suggest that IL-4 production by CD4 and CD8 T cells can occur constitutively in healthy controls with latent TB infection and in TB patients. Cellular IL-4 production may represent a normal cellular growth factor mechanism which is disturbed at the onset of apoptosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17977794     DOI: 10.1016/j.tube.2007.09.001

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  4 in total

1.  Differential expression of interleukin-4 (IL-4) and IL-4 delta 2 mRNA, but not transforming growth factor beta (TGF-beta), TGF-beta RII, Foxp3, gamma interferon, T-bet, or GATA-3 mRNA, in patients with fast and slow responses to antituberculosis treatment.

Authors:  Joel Fleury Djoba Siawaya; Nchinya Bennedict Bapela; Katharina Ronacher; Nulda Beyers; Paul van Helden; Gerhard Walzl
Journal:  Clin Vaccine Immunol       Date:  2008-06-25

Review 2.  Potential of immunomodulatory agents as adjunct host-directed therapies for multidrug-resistant tuberculosis.

Authors:  Alimuddin Zumla; Martin Rao; Ernest Dodoo; Markus Maeurer
Journal:  BMC Med       Date:  2016-06-15       Impact factor: 8.775

3.  Cord Blood CD8+ T Cells Have a Natural Propensity to Express IL-4 in a Fatty Acid Metabolism and Caspase Activation-Dependent Manner.

Authors:  Yuxia Zhang; Jovana Maksimovic; Bing Huang; David Peter De Souza; Gaetano Naselli; Huan Chen; Li Zhang; Kai Weng; Hanquan Liang; Yanhui Xu; John M Wentworth; Nicholas D Huntington; Alicia Oshlack; Sitang Gong; Axel Kallies; Peter Vuillermin; Min Yang; Leonard C Harrison
Journal:  Front Immunol       Date:  2018-04-25       Impact factor: 7.561

4.  Anti-human Interleukin(IL)-4 Clone 8D4-8 Cross-Reacts With Myosin-9 Associated With Apoptotic Cells and Should Not Be Used for Flow Cytometry Applications Querying IL-4 Expression.

Authors:  Robert Z Harms; Kiana Borengasser; Vikas Kumar; Nora Sarvetnick
Journal:  Front Cell Dev Biol       Date:  2019-04-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.